glp-1 and gip dual agonist 🔴Comparison of GLP-1R Mono-Agonist vs. GIPR/GLP-1R Therapy⤵️ #2025Review 1️⃣ RA are well-studied, but the mechanisms of receptor (GIPR) agonists remain less understood. 2️⃣ GLP-1R monotherapy (e.g., semaglutide) is TrimRX | GLP-1 vs GIP:

Aging 2 (3), 283297

The development of targeted compounds, such as those designed to modulate PINK1 phosphorylation and substrate binding, disrupt the BNIP3/NIX homodimer interface, or act as specific LIR motif competitors, remains highly challenging

Not Suitable For: The treatment is not suitable for: Pregnant or Breastfeeding Individuals: Due to potential risks to the foetus or breastfeeding infant

The observed positive outcomes underscore the need for more comprehensive and rigorous research to explore the potential role of FMT in ameliorating gouty arthritis and its associated metabolic abnormalities

The main tests used for the evaluation of TA and TR level as well as to assess GC-dependent side effects, include in vitro molecular profiling of TR and TA-associated genes